Table 3.
Genetic data. Overall comparative analysis of the selected SNPs
| Gen-SNP | Genotype | CAG | COG | p | HWE p |
|---|---|---|---|---|---|
| BMP-4 rs17563 | CC | 20 (27) | 16 (20.3) | 0.597 | 0.696 |
| CT | 34 (45.9) | 41 (51.9) | |||
| TT | 20 (27) | 22 (27.8) | |||
| BRINP3 rs1935881 | AA | 41 (55.4) | 26 (32.9) | 0.012 | 0.073 |
| AG | 25 (33.8) | 45 (57) | |||
| GG | 8 (10.8) | 8 (10.1) | |||
| CD14 rs2569190 | AA | 18 (24.3) | 16 (20.3) | 0.588 | 0.211 |
| AG | 36 (48.6) | 45 (57) | |||
| GG | 20 (27) | 18 (22.8) | |||
| FGF-3 rs1893047 | CC | 17 (23) | 18 (22.8) | 0.688 | 0.928 |
| CT | 32 (43.2) | 39 (49.4) | |||
| TT | 25 (33.8) | 22 (27.8) | |||
| FGF-10 rs900379 | CC | 11 (14.9) | 8 (10.1) | 0.641 | 0.833 |
| CT | 31 (41.9) | 33 (41.8) | |||
| TT | 32 (43.2) | 38 (48.1) | |||
| GBP1 rs7911 | CC | 16 (21.6) | 12 (15.2) | 0.041 | 0.110 |
| CT | 28 (37.8) | 46 (58.2) | |||
| TT | 30 (40.5) | 21 (26.6) | |||
| IL-1α rs1800795 | CC | 9 (12.3) | 6 (7.7) | 0.62 | 0.07 |
| CG | 37 (50.7) | 43 (55.1) | |||
| GG | 27 (37) | 29 (37.2) | |||
| IL-1β rs16944 | AA | 7 (9.5) | 6 (7.6) | 0.795 | 0.401 |
| AG | 37 (50) | 37 (46.8) | |||
| GG | 30 (40.5) | 36 (45.6) | |||
| IL-10 rs1800896 | AA | 23 (31.1) | 33 (41.8) | 0.389 | 0.340 |
| AG | 37 (50) | 33 (41.8) | |||
| GG | 14 (18.9) | 13 (16.5) | |||
| LTF rs1126477 | AA | 5 (6.8) | 3 (3.8) | 0.409 | 0.820 |
| AG | 27 (36.5) | 23 (29.5) | |||
| GG | 42 (56.8) | 52 (66.7) | |||
| OPG rs2073617 | CC | 11 (14.9) | 18 (22.8) | 0.448 | 0.470 |
| CT | 36 (48.6) | 36 (45.6) | |||
| TT | 27 (36.5) | 25 (31.6) | |||
| RANKL rs9533156 | CC | 12 (16.2) | 15 (19) | 0.903 | 0.866 |
| CT | 37 (50) | 38 (48.1) | |||
| TT | 25 (33.8) | 26 (32.9) |
CAG: case group; COG: control group; HWE: Hardy-Weimberg Equilibrium; SNP: single nucleotide polymorphism